0001933414-23-000061.txt : 20230811 0001933414-23-000061.hdr.sgml : 20230811 20230811191115 ACCESSION NUMBER: 0001933414-23-000061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230811 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Congleton Jon CENTRAL INDEX KEY: 0001644975 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41614 FILM NUMBER: 231165710 MAIL ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mineralys Therapeutics, Inc. CENTRAL INDEX KEY: 0001933414 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 N. RADNOR CHESTER ROAD STREET 2: SUITE F200 CITY: RADNOR STATE: PA ZIP: 19087 BUSINESS PHONE: (888) 378-6240 MAIL ADDRESS: STREET 1: 150 N. RADNOR CHESTER ROAD STREET 2: SUITE F200 CITY: RADNOR STATE: PA ZIP: 19087 4 1 wf-form4_169179546088184.xml FORM 4 X0508 4 2023-08-11 0 0001933414 Mineralys Therapeutics, Inc. MLYS 0001644975 Congleton Jon 150 N. RADNOR CHESTER ROAD, SUITE F200 RADNOR PA 19087 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-08-11 4 P 0 2000 12.89 A 1040318 D The price reported is the weighted-average purchase price, purchased in multiple transactions at prices ranging from $12.8522 to $12.9257. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. /s/ Adam Levy, Attorney-in-fact 2023-08-11